HRC 2011 Programme

Presentations are available where the title and speaker are highlighted - click on the link to view. Please note: HRUK Certificate of Accreditation course presentations are only available to delegates who paid to attend these sessions.

Sunday 2nd October

ARRHYTHMIA ALLIANCE PATIENTS DAY
ATRIAL FIBRILLATION ASSOCIATION PATIENTS DAY
STARS PATIENTS DAY
HRUK CERTIFICATE OF ACCREDITATION COURSE: CORE

 Monday 3rd October

A FOCUS ON ANTI-ARRHYTHMIC DRUGS: WHO RULES THE WAVES?
CLINICAL APPLICATION OF HOME MONITORING IN BRADYCARDIA DEVICES
DEVICE BASED STROKE PROPHYLAXIS, A PRACTICAL APPROACH TO HIGH RISK PATIENTS
DEVICES IN INHERITED CARDIAC CONDITIONS
DEVICE ISSUES IN HEART FAILURE AND HEART MUSCLE DISEASE
GENOME TO PRACTICE PRIMER
HANDS-ON SESSION
HEART RHYTHM TRAINEES
HRUK CERTIFICATE OF ACCREDITATION COURSE: DEVICES
INNOVATIVE THERAPIES TO ADVANCE PATIENT CARE
MODERATED POSTERS 1
ORAL ABSTRACTS 1
ORAL ANTICOAGULANTS IN AF: FROM RESEARCH TO PRACTICE
PAEDIATRIC EP
T-LoC/BLACKOUTS: A 360 DEGREE VIEWPOINT

Tuesday 4th October

A BRAVE NEW WORLD:WILL THE NHS REFORMS REALLY CHANGE THE LANDSCAPE?
ABLATION - STORIES FROM THE EXPERTS
ADVANCES IN QUALITY AND EFFICIENCY OF ARRHYTHMIA MANAGEMENT
ALLIED PROFESSIONALS
CHALLENGING DEVICE CASES
CONTROVERSIES WITH ICDS
DEVICE COMPLICATIONS: HOW TO DEAL WITH THEM
DIAGNOSING ICD AND PACEMAKER TRACES
EPIDEMIOLOGY AND CAUSATION OF ATRIAL FIBRILLATION
INNOVATION IN CARDIAC RHYTHM MANAGEMENT
LEFT SIDED SOLUTIONS - ATRIAL FIBRILLATION AND HEART FAILURE
MANAGEMENT OF INAPPROPRIATE SHOCKS IN ICD PATIENTS
MODERATED POSTERS 2
ORAL ANTICOAGULANTS ENTER THE DRAGONS' DEN
STRUCTURE AND FUNCTION OF THE ATRIA
T-LoC/BLACKOUTS: PROVIDING SERVICES
VENTRICULAR TACHYCARDIA IN STRUCTURAL HEART DISEASE (1)
YOUNG INVESTIGATORS COMPETITION

Wednesday 5th October

ANTIARRHYTHMIC THERAPY FOR ATRIAL FIBRILLATION
ANTITHROMBOTIC MANAGEMENT OF ATRIAL FIBRILLATION
CASES AND TRACES
HRUK CERTIFICATE OF ACCREDITATION COURSE: ELECTROPHYSIOLOGY
ORAL ABSTRACTS 2
VENTRICULAR TACHYCARDIA IN STRUCTURAL HEART DISEASE (2)
WHAT TO DO WHEN THE BATTERY RUNS DOWN

ARRHYTHMIA ALLIANCE PATIENTS DAY - The National Patient Group Meeting: Living with, Treating and Managing Arrhythmias

Sunday 2nd October 2011 10:30 - 16:00
Salisbury

Information, Support and Advice

Chair: J Tagney  
10:30 Welcome                                                              J Tagney
10:40
How a patient group works for you                        S Shunmoogum
11:00 What you can expect from A-A: Bridging the gap                                     C Holmes
11:20 Your guide to successful fundraising     W Adams
11:40 Defibrillators in the community                  J Eden
11:55 Getting the most from your Arrhythmia Nurse J Maloney
12:15 Question Time                                                                            
12:30 Lunch                                                              
 

Your Questions Answered

Chair: W Adams                
13:30 Exercising with an Arrhythmia: Your questions answered A Wolff
13:50 Dos and don'ts of travelling - Information for your Support Group S Jones
14:10 Living with devices J Tagney
14:30 Ask the expert panel of speakers J Eden
S Jones
S Shunmoogum
J Tagney
A Wolff
15:00 Summing up and feedback W Adams       
15:15 Meet and chat  
16:00 Close                      

ATRIAL FIBRILLATION ASSOCIATION PATIENTS DAY

Sunday 2nd October 2011 10:30 - 16:00
Churchill & Gladstone

Assessing the Risks & What Other Drugs Might I be Given?

Chair: A Wolff    
10:30
Message of thanks from the AFA team J Jerrome        
10:45 Assessing risks
> Anti arrhythmic drugs/beta blockers/why are they used?/side effects/ place in treatment pathway
C Cowan
11:15 Stroke prevention in atrial fibrillation
> What is anticoagulation?
> Emerging treatment options (including devices), but which is for me
and will I be automatically offered any of these new options?
 
M Earley

Other Options for Treating AF

Chair: A Wolff
 
11:45 When is catheter ablation an option? G Thomas
12:05 What is minimally invasive surgical ablation and who might be suitable for this?
J Hyde
12:25 Pace and ablate: the risks and the benefits J Pitts-Crick      
12:45 Lunch
      

AF and You

Chair: J Maloney                    
13:45 I am healthy but I have AF, what lifestyle changes can I make to help? M Fay
14:15 I feel so lonely, are there any support services which could help? J Maloney

Discussion

Chair: M Fay                    
  In the new commissioning of NHS services, where will AF be managed and
what is my entitlement to accessing specialist AF?
 
14:45 Redress unwarranted inequalities in access - The Role of Commissioning J Howell
15:05 What does a successful model of care look like? D Bruce
15:20 AF in Primary Care C Arden
15:40 Specialists in AF - timely referrals to improve outcomes M O'Neill
16:00 Close  


STARS PATIENTS DAY

Sunday 2nd October 2011 10:00 - 15:45
Terrace

Diagnosis

Chair: B Karabin                                                                                            
10:00 How to communicate with your GP                                M Fay           
10:30
Use of ILRs, how they are implanted, after care            N Linker      
11:00 Break                                                                             
                    

Syncope Affects All Ages

Chair: J Cozon                                                                        
11:10 Growing up with RAS - crossing over from childhood to adolescence W Whitehouse
11:35 My experience of syncope at 17 years          K Kavi
11:45 Syncope we grow older L Kavi
12:05 POTS and Syncope: How I manage work and my recent experience of
pregnancy
A Kiernan
12:30 Lunch                            

 Syncope Treatment and Support

Chair: T Lobban                 
13:30 When is it time to consider a pacemaker in a child?
K McLeod
14:00 POTS - diagnosis and treatment options
G Thomas
14:15 POTS and Syncope: Understanding why people faint and what
can be done about it
B Karabin
15:00 Question Time                         
15:30 Message of thanks from the STARS team T Lobban
15:45 Close
                

HRUK CERTIFICATE OF ACCREDITATION COURSE: CORE

Sunday 2nd October 2011 13:00 - 17:15
Arden

Chair: N Linker
                      
13:00 Exam overview N Linker
13:15 "Electrical" anatomy of the heart D Begley   
13:50 Arrhythmia mechanisms N Davidson
14:25 Introduction to electrophysiology
K Bain
15:00 Tea / Coffee  
Chair: S Allen  
15:30 Drugs and the heart N Linker
16:05 Clinical trials in arrhythmia management
S Allen
16:40 Introduction to cardiac device function and troubleshooting A Turley
17:15 Close  

A FOCUS ON ANTI-ARRHYTHMIC DRUGS: WHO RULES THE WAVES? (Sponsored by sanofi)

Monday 3rd October 2011 08:30 - 12:15
Salisbury & Wellington

A Look at the Role of Anti-arrhythmic Drugs in the Treatment of Atrial Fibrillation, with a Specific Focus on Guidelines and Patient Types

Chair: N Peters                                                 
08:30 Introduction by the Chair  
08:40 How do the current anti-arrhythmic drugs compare?    N Sulke          
08:55 What do the current guidelines tell us? N Peters
09:10 Case studies of typical AF patients
> The role of the cardiologist
> The role of the electrophysiologist

A Bakhai
K Rajappan
09:30 Panel discussion  
10:00 Tea / Coffee               

Maximising the Benefits of Anti-arrhythmic Drugs: A Discussion around the Care Pathway and Guidance on when to introduce an Anti-arrhythmic Drug into the Patient Treatment Plan

Chair:    
A J Camm  
10:45 Introduction by the Chair
 
10:50 Models of care in AF - do we know what we're doing?
K Khan
11:05 Models of care in AF - hospital based services A Bakhai
11:20 To anticoagulate or not to anticoagulate, in patients who need an AAD M Fay
11:35 Multidisciplinary Masterclass
> I would use an AAD in these patients
> I would not use an AAD in these patients

Discussion/ Q & A
A J Camm & Panel
12:15 Close
 

 

CLINICAL APPLICATION OF HOME MONITORING
IN BRADYCARDIA DEVICES (Sponsored by Biotronik)

Monday 3rd October 2011 08:30 - 12:15
Oxford

Chair: D Fluck & R Kaba
           
08:30 Experience and outcomes of Home Monitoring in pacemakers D Fluck        
09:00 Added benefits of Home Monitoring for bradycardia devices -
what's in it for the electrophysiologist?
E Rowland   
09:30 Comparing the utility of Home Monitoring for bradycardia and
tachycardia devices

J Wright       
10:00 Tea / Coffee                          
10:45 Use of Home Monitoring technology in specific circumstances -
case studies
A M Choy    
11:10 Understanding the optimal application of Home Monitoring in
the day to day clinical setting
S Allen
11:30 Troubleshooting pacemakers remotely - case studies P Foley        
11:50 Monitoring your patient, not device malfunctions, the true benefits
of Home Monitoring
I Clement 
12:15 Close                    


DEVICE BASED STROKE PROPHYLAXIS, A PRACTICAL APPROACH TO HIGH RISK PATIENTS (Supported by an educational grant from AGA Medical)

Monday 3rd October 2011 13:30 - 17:15
Oxford

Chair:    
A J Camm, J Morgan & R Schilling
 
13:30 Introduction R Schilling
13:35 Anatomy of the Left Atrium and it's role for thromboembolic events                               A Cook
14:00 Imaging of the LAA and device placement
J Newton
14:25 New drugs, new trials - how does LAA occlusion fit? D Begley
14:50 Panel Discussion                               
15:00 Tea/Coffee                                                              
                 
15:45 The new factor with increased pressure in health care spending; how to gain funding for this procedure E Rowland
16:00 Device based alternative for stroke prophylaxis, Case 1 P Kanagaratnam
16:20 Device based alternative for stroke prophylaxis, Case 2 
M Earley
16:40 Device based alternative for stroke prophylaxis, Case 3
J Morgan
17:00 Panel Discussion  
17:10 Summary A J Camm
17:15 Close                    


DEVICES IN INHERITED CARDIAC CONDITIONS

Monday 3rd October 2011 15:45 - 17:15
Cambridge

Chair:
C Garratt                                                                            
15:45 Hypertrophic cardiomyopathy                                           P Elliott
16:10 ARVC                                                                                P Lambiase
16:30 Long QT syndrome                                                          E Behr
16:55 Brugada Syndrome                                                     D Connelly
17:15 Close  


DEVICE ISSUES IN HEART FAILURE & HEART MUSCLE DISEASE

Monday 3rd October 2011 13:30 - 15:00
Cambridge

Chair:   
M O'Neill  
13:30 Treatment to suppress ventricular ectopy in heart failure D Begley
14:00 Device and ablation therapy in myptonic dystrophy, sarcoid, amyloid etc
> Cardiomyopathy & Devices
> Intervention

J Bourke
K Rajappan        
14:30 What have we learnt from CRT trials in mild heart failure?
M Gold
15:00 Close  


GENOME TO PRACTICE PRIMER

Monday 3rd October 2011 08:30 - 12:15
Cambridge

Monogenic Diseases: Mechanisms and Models

Chair: A Grace & P Lambiase                                      
 
08:30 Inherited Cardiomyopathies                         H Ashrafian
09:00 Ion channel disease                                          E Behr
09:30 Stem cell-based disease models                                    
H Ayetey
10:00 Tea / Coffee                                                                     
 

Complex Diseases: Genes and Function

Chair: H Ashrafian & N Peters                                                                  
10:45 Genetics of Atrial Fibrillation P Ellinor
11:15 Arrhythmogenic molecular and structural remodelling
M Boyett
11:45 Genetics and Sudden Death in Heart Failure A Grace 
12:15 Close     
              


HANDS-ON SESSION

Monday 3rd October 2011 13:30 - 17:15
Arden

Come and view the latest advances from Biotronik, Boston Scientific, Medtronic, Sorin & St Jude Medical


HEART RHYTHM TRAINEES - "HOW TO..."

Monday 3rd October 2011 17:30 - 19:00
Oxford

Chair: A Opel
 
17:30 How to write a grant and get it accepted                         A Tinker
17:45
How to write an abstract and get it accepted                 
N Peters
18:05
How to review a paper for a journal                               I Savelieva
18:20 How to be a better presenter and tackle difficult questions A J Camm
18:40 How to be a better leader R Schilling
19:00 Close          
                     

HRUK CERTIFICATE OF ACCREDITATION COURSE: DEVICES

Monday 3rd October 2011 08:30 - 12:15
Arden

Chair: C Regan
 
08:30 Implanting devices - a practical guide                                     S Harris
09:00 The physics of implantable devices                               
M James
09:30 Pacemaker troubleshooting C Regan
10:00 Tea/Coffee                                                              
                 
Chair: K Lascelles                       
10:45 ICD troubleshooting C Joyce
11:15 CRT troubleshooting                     
K Lascelles
11:45 Recalls and faults - how to deal with them
M Squirrell
12:15 Close                    

INNOVATIVE THERAPIES TO ADVANCE PATIENT CARE (Sponsored by St Jude Medical)

Monday 3rd October 2011 13:30 - 17:15
Salisbury & Wellington

CRM Session

Chair: 
C A Rinaldi
              
13:30 CRT Challenges - Greater Efficiency and Optimal Response C A Rinaldi    
14:00 MRI - Patient Benefits of 4w/Kg (Max Power Scanning) M Schmitt
14:30 Implantable Monitors for Heart Failure - The Preferred Tool?
T Betts
15:00 Tea / Coffee
               

EP Session

Chair:     
P Della Bella                
15:45 Innovation in Ablation Technology - Saving you Time and Improving Patient
Outcomes
P Della Bella      
16:15 VT Consensus Document - What is it? What does it mean for your practice?
S Murray   
16:45 Fluoroscopy Time in Ablation - Minimsing the Risk A Chow     
17:15 Close
                


MODERATED POSTERS 1

Monday 3rd October 2011 12:45 - 13:15
Monarch Suite Foyer

Abstract Numbers 31 - 38

Chair:   
C Pepper & K Rajappan              
 31 High Rate of Appropriate Therapy Justifies ICD Use in Elderly Patients W Nicolson
 32 First Experience of a New Remote Catheter System for Ablation of
Atrial Fibrillation Using 3D Mapping Systems
P Brown
 33 Mitral Isthmus Ablation is Feasible, Effacious and Safe Using
Robotic Remote Navigation System
K Wong
 34 Persistent Atrial Fibrillation Guided by Selective Continuous Activity Mapping:
Towards more Effective Targeting of Fractionated Sites
PB Lim
 35 Complex Cardiac Device Implantation in a Large District General Hospital -
Can it be done well?
LTM Yung
 36 Cost Analysis of Early Cardiac Device Infections B Saberwal
 37 Patient Satisfaction with Nurse-Led Follow Up Service for Atrial Fibrillation
facilitated by Implantable Reveal XT Devices
M Castro
 38 Should Persistent Atrial Fibrillation always be Managed in Secondary Care?
A Comparative Study of Current Practice
A Jordan
13:15 Close                                 
                            


ORAL ABSTRACTS 1

Monday 3rd October 2011 13:30 - 17:15
London

Atrial Fibrillation

Chair:   
N Peters
                  
13:30 The Use of Oral Anti-coagulants in the Management of Atrial Fibrillation.
National Data from GRASP-AF                                 
C Cowan
13:45
The Increasing Burden of Atrial Fibrillation on Healthcare in Scotland                                   AM Choy
14:00
A Randomised Controlled Trial of Catheter Ablation vs. Medical Treatment
of Atrial Fibrillation in Heart Failure (The CAMTAF Trial)
R Hunter                
14:15 A Randomised Trial of Cyroablation vs. Radiofrequency Ablation vs.
Both for Paroxysmal AF
E Duncan
14:30 Does Catheter Ablation of Atrial Fibrillation Reduce Risk of Stroke and Death? R Hunter
14:45 Ablation for Atrial Fibrillation - The Impact of Repeat Procedures -
10 Years of Single Centre Experience
P Brown
15:00 Tea / Coffee  

Cardiovascular Implantable Electronic Devices

Chair:   
J Bourke        
15:45 High Rate of Appropriate ICD Therapy in Dilated Cardiomyopathy in
UK Clinical Practice
W Nicolson
16:00
An Atrial Lead does not Lower the Inappropriate ICD Therapy Rate
in Patients with AF
W Nicolson
16:15
Single Centre Experience of MR-Conditional Pacemaker Leads:
No Difference in Complication Rates and Procedure Times Compared With
Use of Standard Leads
S Little
16:30 Cardiac Implantable Electronic Device Infection may be Successfully Managed
with a Reburial Strategy in Selected Patients
M Das
16:45 Survey of Antibiotic Prophylaxis for Implantable Cardiac Electronic Devices
(ICED) Insertion
E Lowe
17:00 Percutaneous Lead Extraction in Octogenarians S Williams
17:15 Close                             

ORAL ANTICOAGULANTS IN AF: FROM RESEARCH TO PRACTICE (Supported by NHS Improvement)

Monday 3rd October 2011 08:30 - 12:15
London

What is the Evidence?

Chair: C Cowan                                                                                       
08:30 Introduction                                                                          C Cowan 
08:35
Stroke risk and AF: The evolving national picture               M Fay      
09:15 AF, a silent epidemic? How to find the missing quarter      A Wolff     
10:00 Tea/Coffee                                                                
                

Evidence in Practice

Chair:   
R Healicon              
10:45 Oral anticoagulant protocols in practice: The Greater Manchester
approach to the introduction of new anticoagulation therapies
A Fitchet
J Ratcliffe
11:05 Contraindications to oral anticoagulation M Smith
11:25 The importance of time in therapeutic range C Cowan
11:50 The changing face of anticoagulation, medication and service provision R MacLean
12:15 Close                        


PAEDIATRIC EP

Monday 3rd October 2011 08:30 - 12:15
Churchill & Gladstone

Chair:  
J Till & O Uzun
 
08:30 Recreational drugs and arrhythmias in younger children A Ghuran  
09:15 Home telemetry for children with pacemakers and AICDs -
Benefits and limitations

J McComb
10:00 Tea/Coffee
   
Chair: A Duke & J Skinner    
10:45 New modalities for mapping incisional tachycardias following surgery
for congenital heart disease
M Lowe     
11:30 Ablation in infants: indications, limitations, challenges and results
E Rosenthal
12:15 Close                  

T-LoC/BLACKOUTS: A 360 DEGREE VIEWPOINT
(Sponsored by STARS)

Monday 3rd October 2011 13:30 - 17:15
Churchill & Gladstone

Chair:    
A Fitzpatrick
 
13:30 Can I deal with it here? The view from General Practice M Fay
14:00 Can this one go home or stay in? The view from Casualty C Mann
14:30 Is it in the Heart? The view from Cardiology           
N Gall
15:00 Tea / Coffee  
Chair: J Bayliss  
15:45 Is it in the Autonomic System? The view from an Autonomic Disorders Clinic B Karabin
16:10 Is it in the Head? The view from Neurology
T Von Oertzen
16:35 Is it in the Age? The view from Elderly Care E Brierley
17:00 Round Table Discussion - Questions & Answers                      
17:15 Close  

A BRAVE NEW WORLD: WILL THE NHS REFORMS REALLY CHANGE THE LANDSCAPE? (Sponsored by PCCS)

Tuesday 4th October 2011 08:30 - 17:15
London

Atrial Fibrillation in the Post White Paper World

Chair:  
K Griffith                     
08:30 The role of the third sector                                                                     J Jerrome
09:00
The role of the professional organisations                           K Griffith   
09:30 NHS Structures: Heart and Stroke Networks    P Mercer               
10:00 Tea/Coffee                                                                   
 

Arrhythmia Services in the Post White Paper World

Chair:  
M Fay                    
10:45 New anticoagulants in a time of austerity                                        M Bull
11:15 'No decision about me without me'                         M Ellis
11:45 New structures and organisations                          S Hepplewhite
12:15 Lunch  

 Syncope in the Post White Paper World

Chair: A Wolff                                                                                    
13:30 NICE and T-LoC    
N Gall       
14:00 The perspective of the patient
A Morris
14:30 The T-LoC clinic - value for money? A Fitzpatrick
15:00 Tea/Coffee
           

The Big Quiz Rematch

Chair:       
H Purcell                                                                                                   
15:45 The teams from last year's 'Big Quiz' will once again be pitted against each other - one side being the GPwSIs and the other cardiologists from secondary and tertiary care.                         
  Team 1 - GPwSI C Arden
D Fitzmaurice
K Griffith
  Team 2 - Consultants  B Brown
L Graham
A Zaidi
17:15 Close                                                                                             
                           


ABLATION - STORIES FROM THE EXPERTS

Tuesday 4th October 2011 10:45 - 12:15
Lancaster

Chair:  
S Furniss                                     
10:45 An AF ablation complication J Bourke     
11:15 AF ablation - pre-recorded case (Biosense Webster) R Schilling  
11:45 A challenging VT case with a complication - How I managed it P Della Bella    
12:15 Close    
                   

ADVANCES IN QUALITY AND EFFICIENCY OF ARRHYTHMIA MANAGEMENT
(Sponsored by Medtronic)

Tuesday 4th October 2011 08:30 - 12:15
Cambridge

Chair:    
R Schilling
                    
08:30 Latest experience in reducing shocks - what is the impact? M Sopher           
09:00 Lean and mean...how to streamline your remote follow up service A Zaidi
09:30 Remote monitoring - The era of data R Gough
10:00 Tea / Coffee  
Chair: M Sopher  
10:45 A randomized trial of Cyroablation vs. Radiofrequency Ablation vs.
both for PAF: Results to date
R Schilling
11:15 EU phased RF experience: what we have learned and what we need
to know next

S Murray
11:45 Innovative use of Reveal XT in Cryptogenic stroke patients M Belham    
12:15 Close                          


ALLIED PROFESSIONALS

Tuesday 4th October 2011 08:30 - 17:15
Salisbury & Wellington

Chair:       
J Upright  
08:30 An overview of last year's trials and what do they mean for CRM? J de Bono
09:00 Antithrombotic treatment in AF, with a focus on the ESC & ACC/AHA guidelines                                                 N Gall
09:30 Advancements in medicine -  an overview K Rajappan
10:00 Tea/Coffee                       
Chair: A Griffiths  
10:45 What's new in implants? S Allen
11:15 Device case studies S Allen
12:15 Lunch  
Chair: S Allen  
13:30 Implantable loop recorders - Current controversies J Upright            
13:50 An inter-professional approach to VT ablation I Wright
14:10 Supporting the device patient, from the allied health professionals perspective S Jones             
14:30 Brugada syndrome, where are we now? P Lambiase
15:00 Tea / Coffee                        
15:45 Allied Professionals Meeting - Arrhythmia Nurses
 
Chair: A Griffiths, J Maloney  
     
 15:45 Allied Professionals Meeting - Cardiac Physiologists  
Chair: S Jones, C Joyce                                 
 17:15 Close
                          


CHALLENGING DEVICE CASES

Tuesday 4th October 2011 15:45 - 17:15
Churchill & Gladstone

Chair:
D Connelly  
15:45 ICD implant                                                                      M Dayer
16:15 Lead extraction                                                  C A Rinaldi  
16:45 CRT implant A Rao   
17:15 Close                     


CONTROVERSIES WITH ICDS

Tuesday 4th October 2011 13:30 - 15:00
Lancaster

Chair:
M Hall  
13:30 Dual chamber versus single chamber?     M Mason  
14:00 Should we do DFT tests for primary prevention implants? N Davidson  
14:30 How to manage the faulty ICD lead A Zaidi
15:00 Close  


DEVICE COMPLICATIONS: HOW TO DEAL WITH THEM

Tuesday 4th October 2011 13:30 - 15:00
Churchill & Gladstone

Chair:   
M Gammage  
13:30 HRUK competencies statement for implantable cardiac devices -
what are the implications?
C Plummer
14:00 Implantation procedure - antibiotics? Sutures? Ioban? Collatamp?
Rifampicin mesh?
J Wright            
14:30 Bridging therapy/antiplatelets (i.v. heparin, LMWH, dual antiplatelets) A Rao
15:00 Close  


DIAGNOSING ICD AND PACEMAKER TRACES

Tuesday 4th October 2011 08:30 - 10:00
Lancaster

Chair:
S Jones  
08:30 Pacemaker cases                                                    M Mason
09:00 ICD cases from Liverpool                   D Todd 
09:30 ICD cases from a DGH centre J Timperley
10:00 Close  

EPIDEMIOLOGY AND CAUSATION OF ATRIAL FIBRILLATION (Sponsored by AFA)

Tuesday 4th October 2011 15:45 - 17:15
Arden

Chair:  
P Ellinor & A Grace  
15:45 Introduction  
15:50 Genetic Basis for Atrial Fibrillation                              P Kirchhof
16:15 Electrophysiological Determinants of Atrial Fibrillation    A Grace           
16:45 Clinical Causes, Associations and Risks of Atrial Fibrillation I Savelieva
17:10 Summary                                                     
17:15 Close                     


INNOVATION IN CARDIAC RHYTHM MANAGEMENT

Tuesday 4th October 2011 10:45 - 12:15
Oxford

Chair:    
J McComb                       
10:45 Screening for pacing indication in primary care; how to do it C Plummer       
11:15 AF and heart failure - AF ablation or Bi-V with AV node ablation? M O'Neill
11:45 Strategies for minimizing ICD shocks M Gold          
12:15 Close                       

LEFT SIDED SOLUTIONS - ATRIAL FIBRILLATION AND HEART FAILURE (Sponsored by Boston Scientific)

Tuesday 4th October 2011 13:30 - 17:15
Cambridge

Chair:   
J Foran
 
13:30 LAAO - The Data, The Device and Starting a Service T Betts
M Buch
  Talks and case presentation about LAA Occlusion
> The history of LAAO and the clinical data
> The Watchman device, case presentations and tips and tricks
> Setting up an LAAO service (finding patients and securing funding)
 
15:00 Tea / Coffee  
Chair: H Klein  
15:45 Life after MADIT-CRT P Lambiase
M McIntyre
J Wright           
16:05 Round table discussion on: How best to "capture" (identify, refer) the
appropriate patients
> Primary lessons from MADIT-CRT (and REVERSE and RAFT)
> New insights from the sub-studies
> Health Economics considerations of Guideline revision
                       
17:15 Close  


MANAGEMENT OF INAPPROPRIATE SHOCKS IN ICD PATIENTS

Tuesday 4th October 2011 08:30 - 10:00
Oxford

Chair:   
N Linker  
08:30 Atrial fibrillation T Betts
09:00 SVT A Morley-Davies
09:30 Non arrhythmic causes, recognitition and management                 D Connelly
10:00 Close  


MODERATED POSTERS 2

Tuesday 4th October 2011 12:45 - 13:15
Monarch Suite Foyer

Abstract Numbers 39 - 46

Chair:      
A Grace & A Rankin                 
 39 Long QT3 Mice have Disrupted Sympathovagal Balance and in Vivo
Ventricular Stimulation does not determine Risk of Sudden Cardiac Death,
Suggesting that a Second Perturbation to Increase Vagal Tone may be Critical
A Opel                  
 40 RGS 4 KO Mice are Predisposed to Atrial Fibrillation (AF) and Show Disrupted
Sympathovagal Balance in Vivo, Making RGS 4 a Potential Novel Therapeutic
Target for AF
A Opel
 41 Arrhythmic Burden in Families with Hypertrophic Cardiomyopathy related to
Myosin Binding Protein C Mutations
S Page
 42 LV Pacing and the Difference in Acute Haemodynamic Response within
Individual Branches of the Coronary Sinus
A Shetty
 43 Benefits of Endocardial and Multi-Site Pacing are dependent on the LV
Electrical Activation Pattern and Presence of Ischaemic Heart Disease:
Insights from Electro-anatomical Mapping
M Ginks
 44 The Electrophysiological Characteristics of Ventricular Arrhythmias and their
relation to Cardiac Phenotype in Hypertrophic Cardiomyopathy
C O'Mahony
 45 Dynamic Conduction and Repolarisation Changes can help distinguish between
Arrhythmic Right Ventricular Cardiomyopathy and Benign Right Ventricular
Outflow Tract Tachycardia
M Finlay
 46 Characteristics of Eligible Patients who are not referred for Cardiac
Resynchronisation Therapy
V Nayar
13:15 Close
                  

ORAL ANTICOAGULANTS (OACs) ENTER THE DRAGON'S DEN
(Sponsored by Boehringer Ingelheim)

Tuesday 4th October 2011 10:45 - 12:15
Arden

For more information on this session click here.

Chair:      
S Lawley                                                                  
10:45 Dragons                                                                                                             A J Camm
D Jenkinson      

Entrepreneurs S Jarvis
I Menown           
12:15 Close                                                                          
                           

STRUCTURE AND FUNCTION OF THE ATRIA
(Sponsored by AFA)

Tuesday 4th October 2011 13:30 - 15:00
Arden

Chair:   
C Garratt & E Rowland                     
13:30 Introduction  
13:35 The Role of Specialist Commissioning T Daniel
J Howell
14:00 The Left Atrium and its Appendage - Is Echo the right tool? J Newton    
14:30 CMR assessment of Left Atrial Fibrosis M O'Neill
14:55 Summary  
15:00 Close  

T-LoC/BLACKOUTS: PROVIDING SERVICES
(Sponsored by STARS)

Tuesday 4th October 2011 08:30 - 12:15
Churchill & Gladstone

Chair:   
E Brierley
                   
08:30 What do the statistics tell us about T-LoC burden and cost? S Petkar
09:00 Rapid Triage: What are we trying to achieve? A Fitzpatrick
09:30 Setting up a new Blackouts Clinic                 
J Mudd
10:00 Tea / Coffee  
Chair: N Linker  
10:45 Innovative syncope services at the University of Toledo B Karabin
11:10 What do patients worry about?
L Kavi       
11:35 How does STARS support patients and families? T Lobban
12:00 Discussion  
12:15 Close  


VENTRICULAR TACHYCARDIA IN STRUCTURAL HEART DISEASE (1)

Tuesday 4th October 2011 08:30 - 10:00
Arden

Chair:     
C Pepper  
08:30 How to set up an ICD in patients with structural heart disease I Wright
09:00 Ablation for ventricular tachycardia in ICD patients in the UK - first, second
or third line?
J Bourke         
09:30 The place of VT ablation in ICD patients in the USA P Kojodjojo
10:00 Close  


YOUNG INVESTIGATORS COMPETITION

Tuesday 4th October 2011 13:30 - 17:15
Oxford

Judges:    
A Ng (Chair), P Ellinor, C Pepper, A Rankin                     
13:30 Characterisation of Fractionated Atrial Electrograms Critical for Maintenance
of AF: A Randomised Controlled Trial of Ablation Strategies (The CFAE AF Trial)
R Hunter     
14:00 Multipolar Left Ventricular Pacing to optimise Acute Haemodynamic Response
to Cardiac Resynchronisation Therapy
S Ahsan
14:30 Novel Restitution Gradient based Predictor of Ventricular Arrhythmias
W Nicolson
15:00 Tea / Coffee                           
15:45 Electrophysiological Abnormalities Precede Overt Structural Changes in
Arrhythmogenic Right Ventricular Cardiomyopathy due to Mutations in Desmoplakin
J Gomes
16:15 Cardiac Contractility Modulation (CCM) decreases the Ventricular Fibrillation
threshold in the Isolated Rabbit Heart through a Beta1-adrenoceptor Dependent Mechanism
J Winter    
16:45 The Funny Current can be used to create a Biological Pacemaker by Enhancement
of the Pacing Rate of Subsidiary Pacemaker Tissue in a Model of Sick Sinus
Syndrome, but the Effectiveness of Different HCN Isoforms Markedly Differs
G Morris    
17:15 Close  

ANTIARRHYTHMIC THERAPY FOR ATRIAL FIBRILLATION (Sponsored by AFA)

Wednesday 5th October 2011 11:15 - 12:45
Salisbury & Wellington

Chair:    
S Ernst & A Rankin  
11:15 Introduction  
11:20 Cardioversion of Atrial Fibrillation - Electrical vs. pharmaceutical A Rankin
11:45 Dronedarone and other antiarrhythmic possibilites I Savelieva    
12:15 Left atrial ablation - State of the art and what's to come S Ernst
12:40 Summary  
12:45 Close                  

ANTITHROMBOTIC MANAGEMENT OF ATRIAL FIBRILLATION (Sponsored by AFA)

Wednesday 5th October 2011 09:00 - 10:30
Salisbury & Wellington

Chair:      
A J Camm & D Fitzmaurice                           
09:00 Introduction                             
09:05 When and how to use Dabigatran and other new agents S James            
09:30 Triple therapy - Which three drugs and for how long? J McComb            
10:00 Does left atrial ablation or left atrial appendage occlusion obviate anticoagulation F Murgatroyd  
10:25 Summary  
10:30 Close                         


CASES AND TRACES

Wednesday 5th October 2011 09:00 - 15:30
Churchill & Gladstone

Chair:    
S Fynn & M Hall                                                  
 
09:00 ECG diagnosis of Broad Complex Tachycardia D Rowlands
09:30  
Screening families for Inherited Cardiac Conditions...when to start
and when to stop
                                                          
P Lambiase      
10:00  
Pearls & pitfalls of EP manoeuvres
O Segal
10:30 
Tea / Coffee                                                                    
               

Triumphs & Disasters 1

Chair: 
S Fynn & M Hall                                                                        
  
11:15 N Davidson                                                                                       

J Paisey                                                                                             
12:45 Lunch                                                                                             
  

Triumphs & Disasters 2

Chair:  
S Fynn & M Hall                                                                            
      
14:00 S Murray                                                                                         

J de Bono                                                                                       

S Harris                                                                                         
 
15:30 Close                                                                                                      
 

HRUK CERTIFICATE OF ACCREDITATION COURSE: ELECTROPHYSIOLOGY

Wednesday 5th October 2011 09:00 - 12:45
Arden

Chair:       
S Blackman                             
09:00 AVNRT S Blackman
09:30 WPW and other accessory pathways N Grubb
10:00 Ventricular Tachycardia C Pepper
10.30 Tea/Coffee  
Chair: S James  
11:15 Atrial Fibrillation S James
11:45 Atrial Flutter M Wright
12:15 Modern day ablation techniques: an overview of mapping systems and ablation
technologies
I Wright
12:45 Close  


ORAL ABSTRACTS 2

Wednesday 5th October 2011 09:00 - 12:45
Cambridge

Clinical Arrhythmia Practice

Chair:       
F Osman
               
09:00 The Impact of Specialist Nurse Arrhythmia Clinics: Streamlining and Enhancing
Patient Services
S Hackett
09:15
Cost Efficacy Analysis of Current Family Screening Protocol following a Sudden
Arrhythmic Death (SADS)
L Nunn
09:30
Cardiac Resynchronisation Therapy using the Radpad Radiation Shield at Implant significantly reduces Radiation Dose to the Implanting Physician
M Jones                         
09:45 Temporal Trends in the Hospital Burden of Atrial Fibrillation and Stroke on
Secondary Care Costs in England between 2006 and 2009
C Righetti
10:00 Clinical Coding for Electrophysiology and Device Procedures: Why and how
to make it better
A Hogarth
10:15 Pan-Hypopituitarism presenting as Syncopal Long QT J Lane
10:30 Tea / Coffee               

Basic Science and CRT

Chair:      
C A Rinaldi                  
11:15 Enhancement of Gap Junctional Coupling during Acute Myocardial Infarction
reduces Late Post-Infarction susceptibility to Ventricular Arrhythmias
FS Ng
11:30
Electrical Restitution in Single Cells - Effects of Acetylcholine and Nitric Oxide
Donors
R Patel
11:45
Haemodynamic Consequences of Targeted Single and Dual Site Right Ventricular
Pacing in Adults with Congenital Heart Disease undergoing Surgical Pulmonary Valve Replacement
C Plymen
12:00 AV Delay Optimisation of Cardiac Resynchronisation Therapy using Invasive Haemodynamic Measurements is insufficiently Reproducible to be Clinically Useful;
Unless Multiple Replicate Measurements relative to a Reference AV Delay are taken
Z Whinnett
12:15 Is Real-Time CMR Dyssynchrony a Useful Tool in Guiding LV Lead Placement
during CRT?
A Shetty
12:30 Adverse Response to Cardiac Resynchronisation Therapy in Patients with
Septal Scar on Cardiac MRI preventing a Septal Right Ventricular Lead Position
S Duckett
12:45 Close                            


VENTRICULAR TACHYCARDIA IN STRUCTURAL HEART DISEASE (2)

Wednesday 5th October 2011 09:00 - 10:30
Oxford

Chair:    
L Graham  
09:00 Ventricular tachycardia in structural heart disease - the basic science C Garratt
09:30 Evidence based treatment for VT - does everyone need an ICD? D Todd             
10:00 Antiarrhythmic drug treatment at baseline or only after therapy? C Plummer
10:30 Close  


WHAT TO DO WHEN THE BATTERY RUNS DOWN

Wednesday 5th October 2011 11:15 - 12:45
Oxford

Chair:   
M Dayer  
11:15 Patients paced for sinus node disease, now in persistent AF S Harris
11:40 Primary prevention ICD but no therapy delivered M Dayer      
12:00 CRT-D in a patient whose IV function has significantly improved A Turley
12:25 CRT with no clinical benefit P Foley
12:45 Close